Centenary of the UCT Faculty of Health Sciences

SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis

Willem A Hanekom, Anthony Hawkridge, Hassan Mahomed, Thomas J Scriba, Michele Tameris, Jane Hughes, Mark Hatherill, Cheryl L Day, Gregory D Hussey

Abstract


The vision of the South African Tuberculosis Vaccine Initiative (SATVI) (www.satvi.uct.ac.za) is ‘A World Without TB’ and our mission is ‘Innovative and high-quality TB vaccine research in Africa, to impact the global epidemic’. Over the last 10 years, our focus has been twofold: first, clinical trials of BCG and of new candidate vaccines, and second, complementary research that addresses critical questions in TB vaccine development. SATVI is now widely regarded as the leading TB vaccine clinical research site in the world.

Authors' affiliations

Willem A Hanekom, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Anthony Hawkridge, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Hassan Mahomed, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Thomas J Scriba, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Michele Tameris, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Jane Hughes, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Mark Hatherill, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Cheryl L Day, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Gregory D Hussey, South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town

Full Text

PDF (686KB) HTML

Keywords

Tuberculosis vaccine

Cite this article

South African Medical Journal 2012;102(6):438-441.

Article History

Date submitted: 2012-02-24
Date published: 2012-03-02

Article Views

Abstract views: 2052
Full text views: 3855

Comments on this article

*Read our policy for posting comments here